Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 known ✓ | P31645 | 5/20 | 0.53 |
| ▸ | OPRM1 known ✓ | P35372 | 1/20 | 0.52 |
| ▸ | CACNA2D1 | P54289 | 15/20 | 0.58 |
| ▸ | SLC6A2 | P23975 | 12/20 | 0.53 |
| ▸ | SLC6A3 | Q01959 | 5/20 | 0.53 |
| ▸ | MLNR | O43193 | 1/20 | 0.52 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | HTR1A | P08908 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | DRD2 | P14416 | 1/20 | 0.52 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.52 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.52 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.52 |
| ▸ | HTR2A | P28223 | 1/20 | 0.52 |
| ▸ | HTR2C | P28335 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL3993 | 0.91 | CACNA2D1 (0.58) | CACNA2D1SLC6A2SLC6A4SLC6A3MLNR | |
| Oxalic Acid SCHEMBL3799 | 0.89 | SLC6A4 (0.58) | CACNA2D1SLC6A2SLC6A4SLC6A3MLNR | |
| Oxalic Acid SCHEMBL10359725 | 0.87 | SLC6A2 (0.62) | CACNA2D1SLC6A2SLC6A4SLC6A3MLNR | |
| Oxalic Acid SCHEMBL3485 | 0.83 | SLC6A9 (0.47) | CACNA2D1SLC6A4 | |
| SCHEMBL20940180 | 0.81 | CACNA2D1 (0.62) | CACNA2D1SLC6A2SLC6A4SLC6A3MLNR | |
| Oxalic Acid SCHEMBL16347641 | 0.81 | SLC6A4 (0.71) | SLC6A2SLC6A4SLC6A3CYP1A2CYP3A4 | |
| SCHEMBL15809547 | 0.80 | CACNA2D1 (0.57) | CACNA2D1SLC6A2SLC6A4SLC6A3MLNR | |
| SCHEMBL15809763 | 0.80 | CACNA2D1 (0.57) | CACNA2D1SLC6A2SLC6A4SLC6A3MLNR | |
| SCHEMBL15809548 | 0.80 | CACNA2D1 (0.57) | CACNA2D1SLC6A2SLC6A4SLC6A3MLNR | |
| SCHEMBL2600193 | 0.79 | CACNA2D1 (0.75) | CACNA2D1SLC6A2SLC6A4SLC6A3MLNR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5023269-A | 3-aryloxy-3-substituted propanamines | ELI LILLY AND COMPANY (US) | 1991-06-11 | — | — | US | disclosed |
| EP-0273658-B1 | 3-ARYLOXY-3-SUBSTITUTED PROPANAMINES | ELI LILLY AND COMPANY (US) | 1990-10-31 | — | — | EP | disclosed |
| US-4956388-A | ANTIDEPRESSANTS, ANTIANXIETY, TREATMENT OF OBESITY, ADDICTION TO SMOKING AND ALCOHOL | ELI LILLY AND COMPANY (US) | 1990-09-11 | — | — | US | disclosed |
| EP-0273658-A1 | 3-Aryloxy-3-substituted propanamines | ELI LILLY AND COMPANY (US) | 1988-07-06 | — | — | EP | disclosed |